26.09.2015 Views

DRUGS REPORTS

oFF-Patents - iagim

oFF-Patents - iagim

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Drug OFF<br />

Generic Patent<br />

Patent<br />

Name Holder<br />

Marketer<br />

Drugs Off-Patent Reports<br />

Drugs Off-Patent<br />

Reports<br />

ISSN 0793694X<br />

Year of Expiration - 2001<br />

Patent<br />

Expiry<br />

Exclusivit<br />

y<br />

Expiry<br />

Patent &<br />

Exclusivity<br />

Earliest<br />

Generic<br />

Trade Generic NAME Patent # DATE CODES DATE<br />

MM/DD/YY<br />

Calcitriol Calcijex Abbott 1/28/01<br />

inj<br />

4-308-264<br />

Prilosec<br />

Mertaza<br />

pine<br />

Ompera<br />

zole<br />

Astra<br />

Zeneca<br />

4/5/01<br />

4-255-431<br />

1999<br />

2001 1<br />

USD$<br />

(Mil)<br />

1/28/01 - 01/28/01 190<br />

210<br />

3/22/99 U-108 10/01/01 3495<br />

I-23<br />

3540<br />

REMERON Organon P 6/14/01 NCE 06/14/01 132<br />

134<br />

Mevacor Lovastin Merck & Co 6/15/01<br />

4-231-938<br />

Accutane Isotretinoin Roche 8/7/01<br />

[Syntex] 4-464-394<br />

2/8/98 -<br />

I-117<br />

Brimonidine Alphagan Allergan P 9/06/01 -<br />

NCE<br />

PLENDIL Felodipine Merck<br />

& Co.<br />

Xalatan<br />

6/19/01<br />

4-264-611<br />

06/15/01 595<br />

300.<br />

M/D/YY -- 08/07/01 395<br />

462.<br />

09/06/01 98<br />

101<br />

M/D/YY U-3 06/19/01 150<br />

178<br />

Latano<br />

prost<br />

Pharmacia P 6/05/01 NCE 06/05/01 507<br />

417<br />

[207] 4q<br />

levaquin RWJ -- 12/17/01 I-246 12/17/01 288<br />

310<br />

Levofloxacin<br />

Lovenox<br />

Enoxaparin<br />

Na<br />

RPR 12/04/01<br />

4-692-435<br />

Milrinone Primacor Sanofi 2/2/01<br />

4-313-951<br />

Terconazole<br />

TERAZOL J+J 11/09/01<br />

4-358-449<br />

Lisinopril Zestril Astra-<br />

Zeneca<br />

Lisinopril Prinivil Merck<br />

& Co.<br />

Nicorette Nicotine<br />

(Mint) Polacrilex<br />

4q<br />

= Fourth Quarter 2000<br />

12/30/01<br />

4-374-829<br />

12/30/01<br />

4-374-829<br />

05/06/00 U-122<br />

NCE<br />

I-192<br />

12/04/01 299<br />

320<br />

M/D/YY - 02/02/01 101<br />

110<br />

M/D/YY - 11/09/01 103<br />

114<br />

11/24/98 - 12/30/01 600<br />

I-141<br />

646<br />

11/24/98 I-141 12/30/01 350<br />

365<br />

Pharmacia - - - 12/23/01 234<br />

266<br />

NA = Not Applicable ODE = Orphan Drug Exclusivity NS = New Strength<br />

NCE = New Chemical Entity NE = New Active Salt or Ester NP= New Drug Product<br />

NDF = New Dosage Form NC = New Combination 2001 1 USA + EU Sales<br />

U = Code for Therapeutic Use still I = Code for specific Indication D = New Dosing Schedule<br />

under Patent Protection<br />

under Exclusivity Protection<br />

Drugs Off-Patent Reports 12 Over USD$ 100 million

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!